China Health Industries Holdings, Inc. (CHHE) EPS (Weighted Average and Diluted) (2021 - 2024)
China Health Industries Holdings (CHHE) has disclosed EPS (Weighted Average and Diluted) for 4 consecutive years, with -$0.0 as the latest value for Q1 2024.
- For the quarter ending Q1 2024, EPS (Weighted Average and Diluted) rose 50.82% year-over-year to -$0.0, compared with a TTM value of -$0.0 through Mar 2024, up 50.82%, and an annual FY2023 reading of -$0.01, down 15.49% over the prior year.
- EPS (Weighted Average and Diluted) was -$0.0 for Q1 2024 at China Health Industries Holdings, up from -$0.01 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.01 in Q4 2022 and bottomed at -$0.01 in Q2 2023.
- Average EPS (Weighted Average and Diluted) over 4 years is -$0.0, with a median of -$0.0 recorded in 2021.
- Peak annual rise in EPS (Weighted Average and Diluted) hit 298.21% in 2022, while the deepest fall reached 2034.22% in 2022.
- Year by year, EPS (Weighted Average and Diluted) stood at -$0.01 in 2021, then skyrocketed by 262.03% to $0.01 in 2022, then tumbled by 147.95% to -$0.01 in 2023, then skyrocketed by 67.96% to -$0.0 in 2024.
- Business Quant data shows EPS (Weighted Average and Diluted) for CHHE at -$0.0 in Q1 2024, -$0.01 in Q4 2023, and -$0.0 in Q3 2023.